Liver atrophy after transcatheter arterial embolization and percutaneous ethanol injection therapy for a minute hepatocellular carcinoma.
A 63-year-old male patient with compensated cirrhosis underwent transcatheter arterial embolization (TAE) and percutaneous ethanol injection therapy (PEIT) for a minute hepatocellular carcinoma (HCC). Although the HCC was successfully treated, esophageal varices worsened and refractory ascites developed 3 months after the TAE and PEIT. Liver atrophy progressed rapidly compared to the natural course of liver cirrhosis.
Motoo
Y
Y
Department of Internal Medicine, Cancer Research Institute, Kanazawa, Japan.
Okai
T
T
Matsui
O
O
Ohta
H
H
Sawabu
N
N
D001284:Atrophy / Q000209:etiology; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D002404:Catheterization; D004621:Embolization, Therapeutic / Q000009:adverse effects* / Q000379:methods; D000431:Ethanol / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007267:Injections; D008099:Liver / Q000473:pathology*; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged
D000431:Ethanol